- Help
- •Contact us
- •About us
- •Sitemap
- •Advertise with the FT
- •Terms & conditions
- •Privacy policy
- •Copyright
© The Financial Times Ltd 2013 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
Mar 6, 2013
Buyout groups line up bid for Life
US-listed biotech group has enterprise value of $12.5bn
From
WORLD
Mar 4, 2013
UK health improvements slowing
US research says action needed to stem tide of avoidable deaths
Mar 4, 2013
Elan pledges royalties-linked dividend
Drug group seeks to counter takeover bid with offer to shareholders
From
TECHNOLOGY
Mar 3, 2013
US doctors say child cured of HIV
Mississippi toddler clear of virus after being put on drugs cocktail
From
WORLD
Mar 3, 2013
Swiss vote for corporate pay curbs
Referendum result even broader than EU bonus caps
©Getty
From
SPECIAL REPORTS
Mar 1, 2013
China: Fears over poor air exacerbate healthcare concerns
The current crisis risks overburdening the country’s creaking medical system
- Developing nations The underworld of expat remittances
- Heady brew Brands target Africa’s emerging middle class
From
TECHNOLOGY
Feb 26, 2013
GSK flu vaccine linked to sleep disorder
Scientists find risk of narcolepsy increased
From
INDUSTRIALS
Feb 26, 2013
Croda cites niche products for sales lift
Speciality chemicals producer banks on consumer care division
Feb 25, 2013
Almirall wary over need to issue shares
Gallardo determined to maintain family’s controlling stake
From
FINANCIALS
Feb 25, 2013
Ireland ripe for M&A surge, says report
Potential deals highlighted in pharmaceutical and medical sectors
Feb 25, 2013
Royalty makes bid to take over Elan
Private equity group in move to gain access to drug income
From
LEX
Feb 25, 2013
Reckitt Benckiser: motorcycle maintenance
The pharma side is proving a creaky sidecar
Feb 25, 2013
Reckitt Benckiser hit by generic ruling
Rival versions of highly profitable Suboxone get green light
Feb 25, 2013
Genus plans further China expansion
Animal genetics group eyes joint ventures in pork farming
From
LEX
Feb 25, 2013
Elan / Royalty Pharma: gone shopping
Which investment banker-turned-pharma executive will investors back?
Feb 24, 2013
Novartis’ U-turn marks a crossroads
Retirement package for Vasella raises investor scrutiny over pay
Feb 23, 2013
Elan unveils share $1bn buyback
Drug group’s plan includes move to seek fresh acquisitions
Multimedia
Offers
JOIN THE BUSINESS ELITEMore people at the top read the FT*
*FT has grown in every major readership survey
*FT has grown in every major readership survey MOST POPULAR NOW ON FT.COM
COMPANIES NEWS ON TWITTER
More FT Twitter accounts
EDITOR’S CHOICE
TOOLS & SERVICES
Multimedia
Tools
- Portfolio
- FT Lexicon
- FT clippings
- Currency converter
- MBA rankings
- Newslines
- Today's newspaper
- FT press cuttings
- FT ebooks
- FT ePaper
- Economic calendar
Return of bear hug would show M&A revival
Royalty Pharma’s bid for Elan is well below a killer price